Results 181 to 190 of about 106,528 (297)

Mechanistic Insights into Qin Bi Yin for Psoriasis Treatment Using Network Pharmacology, Experimental Validation, and Molecular Docking. [PDF]

J Inflamm Res
Zhang S, Du Y, Zhang H, Duan X, Li L.
europepmc   +1 more source

Algorithm for Selecting Ideal Biologic Treatment for Psoriasis

, 2015
Y. Asahina, Sota Kikuchi Koichi Yanaba, Hidemi Nakagawa   +2 more
openalex   +1 more source

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak, Ahmed Javed, Ummi Aiman Rahman, Rumaisa Riaz, Zeeshan Imtiaz, Hassan A. Mirza, Farman U. Khan, Muhid Khattak, Fatima Javid, Abdul Moiz Khan, Adeline L. Roy, Bibek Shrestha   +11 more
wiley   +1 more source

Non-invasive clinical and microscopic assessment methods in evaluating efficacy of moderate-to-severe psoriasis treatment. [PDF]

Chin Med J (Engl)
Wang W, Xu J, Feng Y, Cui Y.
europepmc   +1 more source

A triple-targeting "nano-brake" remodeling the impaired immune microenvironment in skin lesions for psoriasis treatment. [PDF]

Mater Today Bio
Chen R, Duan B, Li S, Zhu Y, Huang Z, Shen D, Ye Z, Yan Y, Qiu C, Guan H, Yao Y, Dong J, Wu F, Jiang X, Shi X, Kou L.   +15 more
europepmc   +1 more source

Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C [PDF]

, 2000
C. Barr Taylor, D.A. BURNS, Martin Wiselka   +2 more
openalex   +1 more source

Serum and Fecal Calprotectin Levels Do Not Alter Significantly in Patients With Psoriasis Switching to Brodalumab After Loss of Effect From TNF‐α Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory skin disease often associated with systemic conditions like psoriatic arthritis and inflammatory bowel disease (IBD). Calprotectin, an inflammatory biomarker commonly used in IBD, has also been found elevated in psoriasis.
Admir Vižlin, Hans‐Peter Claesson, Ylva Andersch Björkman, Martin Gillstedt, Eva Klingberg, Emanuela Micu, Amra Osmančević   +6 more
wiley   +1 more source

Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy

, 2017
Leyla S. Namazova-Baranova, Nikolay N. Murashkin, Eduard Т. Ambarchian, Alexander I. Materikin   +3 more
openalex   +2 more sources

Bra‐Related Chafing in Female Athletes

JEADV Clinical Practice, EarlyView.
Stéphanie Leclerc‐Mercier, Nicolas Kluger   +1 more
wiley   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source